Manfred Welslau, MD: Biosimilars and Patient Access

July 31, 2019

Manfred Welslau, MD, Onkologie Aschaffenburg, Germany, discusses the benefits that biosimilars have in terms of patient access.


Perhaps, for the developing countries, biosimilars are a way to get more people on therapy. I’m thinking of China, thinking of India, thinking of Mexico and the Middle East countries. In these health systems, I think a lot of people are pending getting these medications, so this is a way to help people in these countries to be on therapy.